X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8254) 8254
Publication (621) 621
Book Review (96) 96
Book Chapter (89) 89
Conference Proceeding (23) 23
Dissertation (14) 14
Magazine Article (9) 9
Paper (5) 5
Book / eBook (4) 4
Web Resource (4) 4
Data Set (3) 3
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5173) 5173
index medicus (3859) 3859
animals (2883) 2883
male (2550) 2550
diabetes mellitus, type 2 - drug therapy (2300) 2300
female (1948) 1948
dipeptidyl-peptidase iv inhibitors - therapeutic use (1777) 1777
dipeptidyl peptidase 4 - metabolism (1550) 1550
type 2 diabetes (1515) 1515
endocrinology & metabolism (1470) 1470
hypoglycemic agents - therapeutic use (1411) 1411
middle aged (1327) 1327
diabetes (1324) 1324
glucagon-like peptide-1 (1301) 1301
rats (1173) 1173
pharmacology & pharmacy (1097) 1097
aged (1019) 1019
dipeptidyl-peptidase iv inhibitors - pharmacology (991) 991
mice (986) 986
biochemistry & molecular biology (965) 965
adult (941) 941
dipeptidyl peptidase-iv (903) 903
sitagliptin (862) 862
dipeptidyl peptidase iv (859) 859
glucose (782) 782
dipeptidyl-peptidase iv inhibitors - adverse effects (733) 733
dipeptidyl peptidase 4 (709) 709
treatment outcome (699) 699
analysis (695) 695
dipeptidyl peptidase-4 inhibitor (692) 692
diabetes mellitus, type 2 - blood (675) 675
dipeptidyl-peptidase-iv (674) 674
adamantane - analogs & derivatives (668) 668
expression (647) 647
insulin (621) 621
blood glucose - metabolism (606) 606
metformin (596) 596
cd26 (593) 593
double-blind (591) 591
glycemic control (590) 590
hypoglycemic agents - adverse effects (582) 582
hypoglycemic agents (581) 581
diabetes mellitus (578) 578
research (568) 568
dipeptidyl-peptidase iv inhibitors - administration & dosage (548) 548
sitagliptin phosphate (544) 544
hypoglycemic agents - pharmacology (537) 537
care and treatment (531) 531
drug therapy, combination (519) 519
vildagliptin (511) 511
blood glucose - drug effects (502) 502
peptides (468) 468
cell biology (462) 462
type-2 diabetes-mellitus (460) 460
hypoglycemic agents - administration & dosage (458) 458
peptidase (458) 458
risk factors (450) 450
glp-1 (445) 445
dipeptidyl-peptidases and tripeptidyl-peptidases - metabolism (428) 428
dipeptidyl peptidase-4 inhibitors (426) 426
internal medicine (419) 419
chemistry, medicinal (417) 417
type 2 diabetes mellitus (414) 414
immunology (411) 411
amino acid sequence (410) 410
dipeptidyl peptidase 4 - genetics (407) 407
dipeptidyl-peptidase iv inhibitors (405) 405
drug therapy (405) 405
molecular sequence data (401) 401
safety (401) 401
medicine, research & experimental (400) 400
metformin - therapeutic use (398) 398
glucagon (386) 386
enzymes (385) 385
proteins (384) 384
beta-cell function (376) 376
dextrose (375) 375
efficacy (372) 372
adamantane - therapeutic use (371) 371
diabetes mellitus, type 2 - complications (371) 371
diabetes therapy (370) 370
diabetes mellitus, type 2 - metabolism (365) 365
medicine, general & internal (363) 363
inhibitors (357) 357
dipeptidyl peptidase 4 - blood (356) 356
dpp-4 inhibitor (356) 356
physiological aspects (355) 355
health aspects (349) 349
dipeptidyl peptidase 4 - chemistry (344) 344
glycated hemoglobin a - metabolism (344) 344
proteases (336) 336
medicine & public health (331) 331
triazoles - therapeutic use (330) 330
mellitus (324) 324
pyrazines - therapeutic use (324) 324
dose-response relationship, drug (319) 319
insulin resistance (317) 317
inflammation (316) 316
time factors (315) 315
double-blind method (309) 309
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7970) 7970
German (90) 90
Japanese (70) 70
French (49) 49
Chinese (32) 32
Spanish (32) 32
Korean (22) 22
Russian (22) 22
Czech (21) 21
Hungarian (13) 13
Polish (10) 10
Italian (7) 7
Croatian (4) 4
Danish (4) 4
Dutch (3) 3
Portuguese (3) 3
Turkish (3) 3
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes Care, ISSN 0149-5992, 10/2012, Volume 35, Issue 10, pp. 2076 - 2082
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 02/2012, Volume 340, Issue 2, pp. 248 - 255
Dipeptidyl peptidase (DPP) IV inhibitors are probably beneficial for preventing diabetic complication and modulating glucagon-like peptide-1 receptor (GLP-1R)... 
FIBROSIS | GROWTH-FACTOR-BETA | TGF-BETA | GLP-1 | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE-METABOLISM | BETA-CELL APOPTOSIS | RECEPTOR EXPRESSION | IMPROVES | PHARMACOLOGY & PHARMACY | NEPHROPATHY | Diabetes Mellitus, Experimental - drug therapy | Dipeptidyl Peptidase 4 - metabolism | Gene Expression - drug effects | Kidney - pathology | Gene Expression - genetics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Transforming Growth Factor beta1 - metabolism | Caspase 3 - metabolism | Body Weight - drug effects | Diabetic Nephropathies - drug therapy | Pyrrolidines - administration & dosage | Glucagon-Like Peptide 1 - blood | Male | Insulin - blood | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Glomerular Basement Membrane - pathology | Adamantane - therapeutic use | Diabetes Mellitus, Experimental - complications | Adamantane - administration & dosage | Cyclic AMP - urine | Deoxyguanosine - analogs & derivatives | Kidney - physiopathology | Adamantane - analogs & derivatives | Diabetes Mellitus, Experimental - physiopathology | Receptors, Glucagon - genetics | Adamantane - pharmacology | Diabetic Nephropathies - pathology | Kidney - drug effects | Deoxyguanosine - urine | Diabetic Nephropathies - metabolism | Rats | Receptors, Glucagon - metabolism | Rats, Sprague-Dawley | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Blood Glucose - drug effects | Eating - drug effects | Glomerular Basement Membrane - drug effects | Animals | Glucagon-Like Peptide-1 Receptor | Diabetes Mellitus, Experimental - pathology | Blood Glucose - metabolism
Journal Article
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2014, Volume 36, Issue 12, pp. 2072 - 2079
Abstract Purpose Although recent reports suggest an association between saxagliptin and an increased risk of admissions for heart failure, it is not clear... 
Internal Medicine | Medical Education | DPP-IV inhibition | cardiovascular disease | heart failure | type 2 diabetes | Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) | Vildagliptin in Ventricular Dysfunction Diabetes Trial (VIVIDD) | Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 trial | Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 trial | MYOCARDIAL-INFARCTION | SAXAGLIPTIN | HUMANS | Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 trial | IMPACT | CLINICAL-TRIALS | IMPROVES | PHARMACOLOGY & PHARMACY | TYPE-2 DIABETES-MELLITUS | CARDIOVASCULAR RISK | Dipeptides - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptides - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Pyrrolidines - adverse effects | Uracil - therapeutic use | Hospitalization | Pyrrolidines - therapeutic use | Uracil - adverse effects | Piperidines - therapeutic use | Piperidines - adverse effects | Adamantane - therapeutic use | Sitagliptin Phosphate - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - adverse effects | Heart Failure - chemically induced | Adamantane - adverse effects | Adamantane - analogs & derivatives | Nitriles - therapeutic use | Sitagliptin Phosphate - adverse effects | Uracil - analogs & derivatives | Heart failure | Regulatory agencies | Heart attacks | Peptides | Mortality | Cardiovascular disease | FDA approval | Patients | Data bases | Studies | Diabetes | Drug therapy | Acute coronary syndromes
Journal Article
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 12/2017, Volume 494, Issue 3-4, pp. 452 - 459
Journal Article